MARLINA-T2D
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 09 Jan 2023)
What this means for you
Registered since 30 Aug 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86370644
- Registration number
- 5032430
- Mark type
- Stylized text
- Filed
- 19 Aug 2014
- Published for opposition
- 28 Apr 2015
- Registered
- 30 Aug 2016
- Attorney of record
- Max Moskowitz
Goods and services
- Class 041 — Education and entertainment services: Publication of printed matter with the results of clinical studies involving pharmaceutical preparations
- Class 042 — Scientific and technological services: Medical and scientific research in the field of diabetes; providing medical and sioentific research information in the field of pharmaceuticals and clinical trials
Owner
- Boehringer Ingelheim International GmbH, Ingelheim/Rhein, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
Prosecution history
- 30 Aug 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Jan 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Jan 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Dec 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jun 2022 — TEAS SECTION 8 & 15 RECEIVED
- 30 Aug 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Aug 2016 — REGISTERED-PRINCIPAL REGISTER
- 27 Jul 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Jul 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jul 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jun 2016 — USE AMENDMENT FILED
- 23 Jun 2016 — TEAS STATEMENT OF USE RECEIVED
- 22 Mar 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Mar 2016 — SOU EXTENSION 1 GRANTED
- 23 Dec 2015 — SOU EXTENSION 1 FILED